China Sleep-Wake Disorder Market Size | COVID-19 Impact Analysis | Forecast to 2025

The China sleep-wake disorder market is estimated to grow at a CAGR of 6.5% during the forecast period. China is estimated to have a considerable share in the Asia-Pacific sleep-wake disorder market. Sleep insufficiency, drowsiness, and insomnia are prevalent in Chinese adolescents. Owing to the rapid industrialization and urbanization in the country; the younger adults frequently face career stress and work long hours at night, which interferes with their biological sleep rhythm and leads to insomnia. 

To Request a Sample of our Report on China Sleep-Wake Disorder Market:  https://www.omrglobal.com/request-sample/china-sleep-wake-disorder-market

Parental history of insomnia is linked with elevated risk for insomnia symptoms in adolescents, although adolescent-parent correlations in sleep-wake patterns are comparatively low. Sleep insufficiency is majorly attributable to waking up early in the morning to fullfill school errands. Along with this, the widespread use of social media and other consumer electronics, such as smartphones and computers in younger adults in China, is associated with an increased risk of insomnia.

The market is segmented on the basis of type and treatment. Based on type, the market is sub-segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm disorders, and others. Sleep apnea holds the largest market share during the forecast period. On the basis of treatment, the market is divide into therapies, drugs, and devices. The sleep-wake disorder devices segment is estimated to hold the largest market share during the forecast period, followed by medications.

 (Get 15% Discount on Buying this Report)

A full Report of China Sleep-Wake Disorder Market is Available at:  https://www.omrglobal.com/industry-reports/china-sleep-wake-disorder-market

China Sleep-Wake Disorder Market Segmentation

By Type

·        Insomnia

·        Hypersomnia

·        Circadian Rhythm Disorders

·        Others

By Treatment

·        Therapies

·        Drugs

·        Devices

(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)